Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart Pocock

Showing results (51-60 of 245) with videos related to

Pageof 25
Sort By:
Journal of the American College of Cardiology|May 28, 2016
Short Telomere Load, Telomere Length, and Subclinical Atherosclerosis: The PESA StudyJuan M Fernández-Alvira, Valentin Fuster, Beatriz Dorado, et al.
Contemporary Clinical Trials Communications|July 14, 2021
A re-examination of the SPYRAL HTN-OFF MED Pivotal trial with respect to the underlying model assumptionsMichael Böhm, Martin Fahy, Graeme L Hickey, et al.
Revista Espanola De Cardiologia (English Ed.)|March 15, 2017
Association Between Clinical Pathways Leading to Medical Management and Prognosis in Patients With NSTEACSHéctor Bueno, Stuart Pocock, Jesús Medina, et al.
American Heart Journal|December 25, 2015
The SPYRAL HTN Global Clinical Trial Program: Rationale and design for studies of renal denervation in the absence (SPYRAL HTN OFF-MED) and presence (SPYRAL HTN ON-MED) of antihypertensive medicationsDavid E Kandzari, Kazuomi Kario, Felix Mahfoud, et al.
BMC Emergency Medicine|August 30, 2023
Real world safety of methoxyflurane analgesia in the emergency setting: a comparative hybrid prospective-retrospective post-authorisation safety studyNawab Qizilbash, Himanshu Kataria, Heather Jarman, et al.
Cardiovascular Diabetology|July 11, 2024
Effect of empagliflozin on total myocardial infarction events by type and additional coronary outcomes: insights from the randomized EMPA-REG OUTCOME trialDavid Fitchett, Bernard Zinman, Silvio E Inzucchi, et al.
JACC. Heart Failure|October 31, 2025
Serum Magnesium and the Effect of Empagliflozin in Heart Failure With Reduced Ejection Fraction: Findings From EMPEROR-ReducedJoão Pedro Ferreira, Stefan D Anker, Javed Butler, et al.
Diabetes, Obesity & Metabolism|September 28, 2018
Health-related quality of life in people with type 2 diabetes participating in the LEADER trialMichael A Nauck, John B Buse, Johannes F E Mann, et al.
European Stroke Journal|April 23, 2019
Statistical analysis plan for the 'Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial-2 (RIGHT-2)'Polly Scutt, Jason P Appleton, Mark Dixon, et al.
European Heart Journal|June 22, 2015
Clinical benefits of eplerenone in patients with systolic heart failure and mild symptoms when initiated shortly after hospital discharge: analysis from the EMPHASIS-HF trialNicolas Girerd, Tim Collier, Stuart Pocock, et al.
Pageof 25

Showing results (51-60 of 245) with videos related to

Sort By:
Pageof 25
Journal of the American College of Cardiology|May 28, 2016
Short Telomere Load, Telomere Length, and Subclinical Atherosclerosis: The PESA StudyJuan M Fernández-Alvira, Valentin Fuster, Beatriz Dorado, et al.
Contemporary Clinical Trials Communications|July 14, 2021
A re-examination of the SPYRAL HTN-OFF MED Pivotal trial with respect to the underlying model assumptionsMichael Böhm, Martin Fahy, Graeme L Hickey, et al.
Revista Espanola De Cardiologia (English Ed.)|March 15, 2017
Association Between Clinical Pathways Leading to Medical Management and Prognosis in Patients With NSTEACSHéctor Bueno, Stuart Pocock, Jesús Medina, et al.
American Heart Journal|December 25, 2015
The SPYRAL HTN Global Clinical Trial Program: Rationale and design for studies of renal denervation in the absence (SPYRAL HTN OFF-MED) and presence (SPYRAL HTN ON-MED) of antihypertensive medicationsDavid E Kandzari, Kazuomi Kario, Felix Mahfoud, et al.
BMC Emergency Medicine|August 30, 2023
Real world safety of methoxyflurane analgesia in the emergency setting: a comparative hybrid prospective-retrospective post-authorisation safety studyNawab Qizilbash, Himanshu Kataria, Heather Jarman, et al.
Cardiovascular Diabetology|July 11, 2024
Effect of empagliflozin on total myocardial infarction events by type and additional coronary outcomes: insights from the randomized EMPA-REG OUTCOME trialDavid Fitchett, Bernard Zinman, Silvio E Inzucchi, et al.
JACC. Heart Failure|October 31, 2025
Serum Magnesium and the Effect of Empagliflozin in Heart Failure With Reduced Ejection Fraction: Findings From EMPEROR-ReducedJoão Pedro Ferreira, Stefan D Anker, Javed Butler, et al.
Diabetes, Obesity & Metabolism|September 28, 2018
Health-related quality of life in people with type 2 diabetes participating in the LEADER trialMichael A Nauck, John B Buse, Johannes F E Mann, et al.
European Stroke Journal|April 23, 2019
Statistical analysis plan for the 'Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial-2 (RIGHT-2)'Polly Scutt, Jason P Appleton, Mark Dixon, et al.
European Heart Journal|June 22, 2015
Clinical benefits of eplerenone in patients with systolic heart failure and mild symptoms when initiated shortly after hospital discharge: analysis from the EMPHASIS-HF trialNicolas Girerd, Tim Collier, Stuart Pocock, et al.
Pageof 25